From the Section of Neurobiology, Physiology and Behavior, Division of Biological Sciences, University of California, Davis, Davis, California 95616
![]() |
ABSTRACT |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Using patch voltage-clamp techniques, we find there are two components to the voltage-gated potassium current (IKv) in rat brown adipocytes. The components differ in their gating and responses to purinergic
stimulation, but not their pharmacology. IKv-A recovers from inactivation at physiological membrane potentials,
while IKv-B inactivation recovers at more negative potentials. Both currents are >90% blocked by similar concentrations of quinine and tetraethylammonium, but not by -dendrotoxin, charybdotoxin, or apamin. The two current components are differentially modulated by extracellular ATP. ATP shifts the voltage dependence of IKv-A inactivation negative by 38 ± 5 mV (n = 35, ±SEM) and shifts activation by
14 ± 2 mV in whole-cell experiments. ATP did not affect the steady state inactivation voltage dependence of IKv-B, but did apparently convert
IKv-A into IKv-B. The pharmacology of the inactivation shift is consistent with mediation by a P2 purinergic receptor. Purinergic stimulation of perforated-patch clamped cells causes hyperpolarizing shifts in the window current
of IKv-A by shifting inactivation
18 ± 4 mV and activation
7 ± 2 mV (n = 16). Since perforated-patch recordings will most closely resemble in vivo cell responses, this ATP-induced shift in the window current may facilitate
IKv activation when the cell depolarizes. IKv activity is necessary for the proliferation and differentiation of brown adipocytes in culture (Pappone, P.A., and S.I. Ortiz-Miranda. 1993. Am. J. Physiol. 264:C1014-C1019) so purinergic
modulation of IKv may be important in altering adipocyte growth and development.
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Brown adipocytes have a voltage-dependent K+ current
(IKv)1 that activates with membrane depolarization
(Lucero and Pappone, 1989; Russ et al., 1993
). Brown
adipocyte IKv is similar to delayed rectifier potassium
currents in other nonexcitable cells. IKv activates rapidly with depolarizations positive to approximately
35
mV, inactivates slowly, and deactivates rapidly when the
cell is returned to the holding potential (Lucero and
Pappone, 1989
). The current is blocked by quinine,
verapamil, 4-aminopyridine, and high tetraethyl ammonium concentrations, but not by apamin or charybdotoxin (Lucero and Pappone, 1989
; Pappone and Ortiz-Miranda, 1993
).
Sympathetic nerve stimulation potently regulates
brown fat cell function. Acute adrenergic stimulation
activates membrane conductances, elevates cytosolic
calcium, and increases thermogenesis by activating lipolysis and mitochondrial uncoupling (Nedergaard and Lindberg, 1982; Girardier and Schneider-Picard,
1983
; Horowitz et al., 1983
; Lee et al., 1993
). Chronic
sympathetic stimulation promotes hyperplasia, hypertrophy, and differentiation of brown fat, resulting in increased thermogenic capacity (Geloen et al., 1988
;
Himms-Hagen, 1989
; Bronnikov et al., 1992
). Norepinephrine released by sympathetic nerve activity stimulates both
- and
-adrenergic receptors to depolarize
brown adipocytes, potentially activating IKv.
-Adrenergic stimulation activates a depolarizing Ca2+-dependent
Cl
conductance (ICl,Ca) (Dasso et al., 1990
; Pappone
and Lee, 1995
).
-Adrenergic stimulation activates a
nonselective cation conductance (Horwitz et al., 1989
;
Lucero and Pappone, 1990
). In addition, cell swelling
activates a second depolarizing Cl
conductance (Pappone and Lee, 1995
). These sympathetically induced membrane depolarization events could activate IKv.
IKv is important for brown adipocyte function. IKv is
necessary for proliferation of brown adipocytes in culture (Pappone and Ortiz-Miranda, 1993), but not for
norepinephrine-activated heat production (Pappone
and Lucero, 1992
). The mechanism of IKv's effects on
brown adipocyte growth are not known. Possibly sympathetic activation of IKv is important for cell volume regulation or Ca2+ responses required for cell proliferation. Simultaneous sympathetic activation of ICl,Ca and
IKv in brown fat cells could result in loss of KCl from
the cell and decrease cell volume, as in lymphocytes, epithelial cells, and hepatocytes (Cahalan and Lewis,
1988
; Felipe et al., 1993
; Strange, 1994
; Graf and Haussinger, 1996
). IKv activation could also facilitate Ca2+
entry into the brown adipocyte by increasing the Ca2+
electrochemical gradient, akin to the mechanism described in lymphocytes (Lin et al., 1993
).
The effects of adrenergic stimulation in vitro do not
fully explain the effects that cold exposure or overfeeding have on brown adipose tissue in vivo (Geloen et al.,
1988; Yamashita et al., 1994
), suggesting that additional
agents may contribute to sympathetic actions. Norepinephrine and ATP are colocalized within sympathetic
nerve terminals and may be released simultaneously with sympathetic neuronal activity (Lagercrantz, 1976
;
Westfall et al., 1990
). Moreover, brown adipocytes respond to extracellular ATP. P2 receptor stimulation increases cytosolic Ca2+ and increases membrane turnover and membrane conductances, but does not alter
norepinephrine-elicited thermogenesis (Pappone and
Lee, 1996
; Lee and Pappone, 1997a
).
Channel activity in other cell types can be modulated
by extracellular ATP. P2 receptor stimulation decreases
the activity of voltage-gated K+ currents in hippocampal neurons (Nakazawa and Inoue, 1994) and enhances delayed rectifier K+ current activity in atrial myocytes (Matsuura et al., 1996b
; Matsuura and Ehara,
1997
). Structurally related voltage-gated Ca2+ currents
are inhibited by purinergic stimulation in ventricular myocytes (Qu et al., 1993a
,b; Von zur Muhlen et al.,
1997
) and potentiated in hippocampal neurons (Dave
and Mogul, 1996
). We therefore examined whether extracellular ATP affects IKv in rat brown adipocytes. We
find that brown adipocyte IKv has two components with
different gating properties. One component (IKv-A) is
activated at physiological membrane potentials, while
the other (IKv-B) is inactive under normal conditions.
Extracellular ATP modulates the gating of IKv-A, and
converts IKv-A into IKv-B. A preliminary account of this
work has been presented (Wilson and Pappone, 1996
).
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cells
Brown adipocytes were isolated from the interscapular fat pads of
1-14-d-old Sprague-Dawley rat pups by collagenase digestion and
plated on collagen-coated glass coverslips as previously described (Lucero and Pappone, 1989). Cells were incubated at 37°C and
5% CO2 in Dulbecco's modified Eagle's medium supplemented
with 5% fetal calf/horse serum, 0.2 U/ml insulin, 100 µg/ml
penicillin, 0.1 mg/ml streptomycin, and 0.25 µg/ml amphotericin B. Cells were maintained in culture for 1-14 d before patch
clamping. Mature brown adipocytes for voltage clamp experiments were identified by their many fat droplets.
Electrophysiology
Voltage clamp currents were measured using nystatin perforated-patch (Horn and Marty, 1988) or standard whole-cell patch
clamp techniques (Hamill et al., 1981
) as previously described
(Lucero and Pappone, 1989
, 1990
). Thick-walled borosilicate capillaries (Sutter Instruments, Inc.) were used to manufacture pipettes
with resistances of 3-4 Mohm. Typically, 50% of the 7-10-Mohm
access resistance was compensated at the clamp amplifier. The
voltage offset between the patch pipette and the bath solution
was nulled immediately before patch formation. Membrane currents were recorded, filtered through a four-pole bessel filter at
5 kHz, and membrane capacity currents nulled with the patch
clamp amplifier (3900; Dagan Corp., or Axopatch 200A; Axon Instruments) connected to a computer via a TL-1 (Axon Instruments)
or ITC-16 (Instrutech) interface. Unstimulated cell capacitance
ranged from 20 to 40 pF. Resting membrane potentials measured in current clamp were
20 to
40 mV.
Several different voltage protocols were used. The voltage dependence of activation was determined from currents during
step depolarizations from the 60-mV holding potential (HP) or
after a 3-s conditioning prepulse to
100 mV. The depolarizations ranged from
50 or
60 to +60 mV in 10-mV increments
and were 400-ms long. The time course of ATP action was determined from currents during depolarizations to +40 mV. These
400-ms depolarizing steps were repeated every 20 s or 1 min from
the
60 mV HP or
100 mV prepulse potential. Peak instantaneous tail current amplitude was determined from currents recorded during repolarization from a +40 mV, 400-ms depolarization. The cell was repolarized to potentials from +40 to
60 mV
in 10-mV increments. The voltage dependence of steady state inactivation was determined from currents during depolarizations
after 3- or 6-s conditioning prepulses from 0 to
120 mV. Linear
leak and membrane capacitative currents were subtracted using a
P/4 or P/5 procedure (Armstrong and Bezanilla, 1974
; Lucero
and Pappone, 1989
) in the activation, time course, and tail current protocols. Pulse protocols were delivered and data collected
and analyzed using either pClamp, version 6 (Axon Instruments)
or Pulse, version 8.07 (Instrutech) software.
Solutions
Cells for patch clamp experiments were placed in a 0.5-ml chamber and continuously perfused with either bicarbonate-buffered Krebs solution equilibrated with 95% O2 /5% CO2 at a rate of 1 ml/min or, in most perforated-patch experiments, a low-chloride Ringer's solution with 500 nM apamin, to eliminate Ca2+-activated K+ and Cl
currents (ICl,Ca and IK,Ca). The Krebs solution
contained (mM): 120 NaCl, 4.5 KCl, 0.5 MgCl2, 2 CaCl2, 0.7 Na2HPO4, 1.3 NaH2PO4, 25 NaHCO3, 10 glucose, pH 7.4. The
low-chloride solution contained (mM): 135 Na-aspartate, 4 KCl,
2 CaCl2, 0.5 MgCl2, 10 HEPES, pH 7.4. In some experiments, a
Ringer's solution was used (mM): 135 NaCl, 4 KCl, 2 CaCl2, 0.5
MgCl2, 10 HEPES, pH 7.4. The pipette solution for whole-cell experiments usually contained (mM): 100 K-aspartate, 25 KCl, 10 NaCl, 1 CaCl2, 10 EGTA, 10 MOPS, titrated to pH 7.2 with KOH.
For perforated-patch experiments, the internal pipette solution
usually contained (mM): 115 K-aspartate, 25 KCl, 10 NaCl, 10 MOPS,
0.25 mg/ml nystatin, and 0.1% pluronic F127, titrated
to pH 7.2 with KOH. In some whole-cell experiments, 1 mM ATP
and 0.5 mM MgCl2 were added to the pipette solution. The cytosolic Ca2+ concentration was calculated to be
20 nM for the
whole-cell pipette solution with Patchers Power Tools (F. Mendez, Göttingen, Germany). Osmolarities of the solutions ranged
from 273 to 310 mosM. All chemicals applied to cells were mixed
with the bath solution from thawed frozen stock solutions immediately before application. ATP, 2-methylthio ATP (2-MeSATP),
,
methylene ATP (
,
MeATP), ADP, and adenosine were made
up as 1-100-mM stock solutions in H2O. Nystatin (50 mg/ml) and
pluronic F127 (0.2 g/ml) stock solutions were made up in DMSO.
Chemicals
2-Methylthio ATP and ,
methylene ATP were from Research
Biochemicals Int. or Calbiochem, pluronic F127 was from Molecular Probes, Inc. Nystatin dihydrate was from Fluka Biochemical.
Apamin, charybdotoxin,
-dendrotoxin, quinine sulfate, and tetraethylammonium were from Alamone Labs. All other chemicals
were from Sigma Chemical Co.
Analysis
Peak conductances (G) were calculated from peak current values for the voltage dependence of K+ current activation at each potential assuming that the reversal potential was equal to EK. The conductance values were fitted with the Boltzmann relation:
![]() |
(1) |
where G max was the maximum conductance value, E1/2 the half-maximal activation voltage, Em the membrane voltage, and k the slope factor of the voltage dependence. The voltage dependence of steady state inactivation was described by fitting peak currents (I) during depolarizations from different prepulse potentials with the sum of two Boltzmann relations:
![]() |
![]() |
(2) |
where I max was the maximum current, E1/2 the half-maximal inactivation voltage, Em the membrane voltage, and k the slope factor of voltage dependence. Values in tables are given as the mean ± SEM. Student's t test was performed using a P < 0.05 criterion to test for significance. Either Statview version 4.5 (SAS Institute) or Excel version 5 (Microsoft Corp.) software was used for statistical analysis.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Brown Adipocytes Have Two Voltage-gated K+ Currents
The two components of the voltage-gated K+ current
can be differentiated in brown adipocytes based on
their voltage dependence of inactivation. Fig. 1 A shows
whole-cell currents recorded during depolarizations to
+40 mV after 3-s conditioning pulses from 0 to 120
mV in 10-mV increments. There are clearly two components to the current recovered by the increasingly
more negative conditioning pulses. One component recovers from inactivation completely with conditioning
pulses negative to
50 mV. Additional current is recovered with conditioning pulses negative to
70 mV.
This second current component requires hyperpolarizations negative to
100 mV for complete recovery.
|
Although their inactivation differs, the two current
components share other similarities. Both current components are carried by K+. The combined current is
highly selective for K+ ions, showing a shift in the reversal potential of 56 ± 6 mV (n = 3) per 10-fold change
in extracellular K+ concentration. In addition, the two
components show similar pharmacology. Both are
blocked more than 90% by 50 mM tetraethylammonium (n = 5) or 100 µM quinine sulfate (n = 2), but
are unaffected by 100 nM -dendrotoxin (n = 3), 100 nM
charybdotoxin (n = 3), or 500 µM apamin (n = 17).
The steady state inactivation-voltage relation for
these two voltage-gated K+ currents can be fit by the
sum of two Boltzmann distributions (Eq. 2), as shown
in Fig. 1 B. We have termed the component activated from a 60-mV HP IKv-A. The current component inactivating at more negative potentials is IKv-B. IKv-B inactivates at potentials that average 60-70 mV more negative than IKv-A, as summarized in Table I. Our previous studies of IKv (Lucero and Pappone, 1989
) were
confined to more physiological potential ranges, and so failed to activate this second component of IKv.
|
The voltage dependence for activation of IKv-A and
IKv-B also differ. Fig. 2, A and B, shows IKv activated
from holding potentials of 60 and
100 mV, respectively. Since IKv-A is fully recovered at a holding potential of
60 mV, but IKv-B is inactivated at this potential,
Fig. 2 A presents IKv-A in isolation. Fig. 2 B shows IKv-A
and IKv-B combined since both are fully recovered from inactivation at
100 mV. IKv-B (Fig. 2 C) was isolated by subtracting IKv-A (Fig. 2 A) from the combined current (Fig. 2 B). The conductance-voltage relations for IKv-A and IKv-B can be fit by Boltzmann distributions (Eq. 1), as shown in Fig. 2 D. IKv-B activates
at more negative membrane potentials than IKv-A as
shown in Fig. 2 D and summarized in Table II. The difference in activation voltage dependence between IKv-A
and IKv-B averaged 21 mV, much less than the 60-70
mV difference seen in inactivation voltage dependence. The apparent difference in IKv-B activation voltage dependence is in the wrong direction to be caused
by a Cole-Moore-type shift induced by the
100-mV
prepulse (Cole and Moore, 1960
).
|
|
Table I shows that the inactivation voltage dependence of IKv-A, but not IKv-B, depends on the recording configuration. The midpoint for IKv-A inactivation
averaged 10 mV more positive in perforated-patch than
in whole-cell recordings. Neither IKv-B inactivation nor
IKv-A activation (Table II) showed similar shifts in voltage dependence. Thus, the shift in IKv inactivation is unlikely to be caused by a diffusion potential or general
surface potential difference between the two recording
methods. It is more likely that the difference in IKv-A
voltage dependence result from dialysis of some cytosolic
component in whole-cell recordings. The missing component is not ATP. In whole-cell experiments, the midpoints of IKv-A inactivation and activation were similar,
with or without internal ATP (Tables I and II). The
proportion of IKv carried by IKv-A and IKv-B also differed in whole-cell and perforated-patch experiments.
IKv-A and IKv-B each comprise 50% of total IKv on
average in whole-cell experiments as shown in Table
III. However, the distribution between IKv-A and IKv-B
varied widely from cell to cell, with 0-85% of total IKv
carried by IKv-B. Table III also shows that the distribution of IKv between IKv-A and IKv-B changes with the
recording condition. The apparent redistribution was
due to a 2.5-fold increase in IKv-B magnitude in whole-cell compared with perforated-patch recordings. Neither the total K+ current nor the relative proportions
of IKv-A and IKv-B varied with cell size or the culture
age of the cell.
|
Purinergic Receptor Stimulation Modulates the Gating Properties of IKv-A
P2 receptor activation dramatically decreases the amplitude of IKv-A in whole-cell experiments. Fig. 3 A
shows IKv-A activated during bath application of the P2
receptor agonist 2-MeSATP. 0.05 µM 2-MeSATP decreased IKv-A amplitude without much change in current kinetics. Peak IKv-A declined rapidly within 180 s
after the solution change. Fig. 3 B shows the time
course of the 2-MeSATP effects. The decrease in peak
current was sustained after agonist washout and did not
recover with 5 min of wash in this experiment, or in up
to 30 min in other whole-cell experiments. Holding
currents at 60 mV were not affected by 2-MeSATP,
suggesting that P2 stimulation does not directly activate
ion channels.
|
The decrease in IKv-A with ATP is the result of a hyperpolarizing shift in the voltage dependence of steady
state inactivation. Fig. 4 A shows steady state inactivation measurements before ATP in a whole-cell experiment. In this cell a 60-mV conditioning pulse fully recovered IKv-A, while a
100-mV prepulse fully recovered IKv-B. Fig. 4 B shows that after exposure to 0.3 µM
ATP both IKv-A and IKv-B inactivation were still fully
recovered with the
60- and
100-mV prepulses, respectively, although the midpoint for IKv-A inactivation
was shifted 10 mV negative. After a subsequent exposure to 0.7 µM ATP (Fig. 4 C), IKv-A was shifted even
more, and the two current components could no
longer be distinguished. In general, repeated applications of ATP caused IKv-A inactivation to shift to more
and more negative potentials. The shifts in IKv-A seemed to depend continuously on stimulus duration
and intensity, with no sign of discrete intermediate
states. In addition, there was no end point to the shift
apparent in the achievable range of membrane potentials (i.e., as much or more than
120 mV).
|
The steady state inactivation-voltage relation for the
currents before and after ATP can be well fit by the
sum of two Boltzmann relations (Eq. 2), as shown in
Fig. 4 D. The data in Fig. 4 D suggest that ATP selectively shifts the midpoint for IKv-A inactivation without
affecting its steepness. 0.3 µM ATP shifted the midpoint for IKv-A inactivation 10 mV negative compared
with control currents, while 0.7 µM ATP shifted the
IKv-A midpoint 35 mV more negative than control currents. Corresponding shifts in E1/2 for IKv-B were only
5 and
8 mV, comparable with shifts sometimes seen in whole-cell recordings without purinergic stimulation
over a similar time course.
P2 receptor stimulation caused smaller shifts in the
activation voltage dependence of IKv-A in whole-cell
experiments. Fig. 5 shows that the threshold for detectable IKv-A activation was shifted by approximately 10
mV and the midpoint of the conductance-voltage relation shifted by
13 mV in a cell exposed to 0.02 µM
ATP for 10 min. IKv-A activation shifts with ATP were
consistently approximately one third the magnitude of
inactivation shifts in whole-cell recordings. IKv-B activation voltage dependence was not determined, since both IKv-A and IKv-B components were recovered at
the
100-mV conditioning potential after ATP and
they could no longer be separated.
|
P2 receptor stimulation affects IKv-A currents in perforated-patch clamped cells, but the effects are more
complicated than in whole-cell recordings. IKv-A currents were both increased and decreased by ATP in
cells with an intact cytoplasm. In addition, 10-100-fold
greater concentrations of ATP were required to modulate IKv-A in perforated-patch than were effective in
whole-cell recordings. Fig. 6 A shows peak IKv-A amplitude in a perforated-patch recording during bath applications of ATP. A 30-s application of 5 µM ATP slightly
increased peak IKv-A. ATP increased IKv-A in the cell in Fig. 6 A by shifting the voltage dependence of activation approximately 15 mV. IKv-A inactivation shifted
less (
10 mV) than activation with ATP, in contrast to
whole-cell experiments. Thus, the overall effect of the
initial ATP application was to make more IKv-A activatable at +40 mV, without appreciably affecting the
amount of inactivation present at
60 mV, resulting in
greater IKv-A during depolarization. Initial 30-s exposures to 5 µM ATP caused similar IKv-A increases in 10 of 14 cells. IKv-A decreased in three cells and one cell showed no change in IKv-A amplitude. Repeated exposures to ATP decreased IKv-A in 12 of 14 perforated-patch recordings, as in the example of Fig. 6 A. A second 30-s exposure to 5 µM ATP decreased IKv-A
slightly, while a third, 1-min exposure resulted in an
60% decrease in IKv-A amplitude. ATP transiently increased the leak current measured at
55 mV also.
This could be due to stimulation of Ca2+-activated conductances, since neither Ca2+-activated Cl
or K+ conductances were controlled. Alternatively, a nonselective
cation conductance may have been activated by ATP
(Lee and Pappone, 1997a
). However, this is unlikely
because in other perforated-patch experiments where
the Ca2+-activated K+ and Cl
conductances were
blocked, ATP effects on IKv-A were not necessarily associated with increases in leak currents. Fig. 6 B shows superimposed IKv-A currents during depolarization to
+40 mV, before and after ATP. The initial exposure to
ATP increased the rates of both activation and inactivation. Moreover, as shown in Fig. 6, C and D, ATP
shifted the potential for maximal steady state IKv-A
(window current) to more hyperpolarized potentials.
The potential of the peak window current was shifted
negative by 18 mV, through a
25-mV shift in inactivation and a
23-mV shift in activation. Thus, the effects of ATP on IKv-A in perforated-patch clamped cells are
qualitatively similar to those in whole-cell experiments
in that the voltage dependence of IKv-A gating is
shifted negative. However, there are differences in the
time course, concentration dependence, and magnitude of ATP's effects with recording configuration.
|
The summarized data in Fig. 7 A show that the effects
of ATP on steady state inactivation depend on the recording configuration. ATP (0.01-100 µM for 30 s to
10 min) shifted E1/2 for IKv-A inactivation an average of
38 ± 5 mV more negative in nucleotide-free whole-cell and 18 ± 4 mV more negative in perforated-patch experiments. Over equivalent time periods (i.e., 30 min),
E1/2 for IKv-A and IKv-B inactivation shifted 9 mV
(n = 8) in control whole-cell recordings. Hence, the
38-mV hyperpolarizing shift of IKv-A inactivation with ATP was significantly greater than controls, but the
5-mV hyperpolarizing shift in IKv-B in ATP-treated cells
was not. In the same control whole-cell recordings the
slope for IKv-A and IKv-B inactivation decreased, and
the slope variable, k, increased by 2-6 mV over the 30 min. Thus, the 0-4-mV increase in k after ATP for IKv-A and IKv-B was not different from controls. Overall, the
results show that ATP selectively shifts the voltage dependence of IKv-A steady state inactivation, and this effect is greater in whole-cell than in perforated-patch recordings.
|
The effects of ATP on the activation voltage relation
for IKv-A also depend on the recording configuration.
As summarized in Fig. 7 B, ATP shifts E1/2 for IKv-A activation 14 ± 2 mV in nucleotide-free whole-cell recordings and
7 ± 2 mV in perforated-patch experiments. In whole-cell experiments not stimulated with
ATP, E1/2 for activation only shifted
2 ± 2 mV in 30 min. The slope variable, k, was not affected by ATP. In
both control and ATP-stimulated whole-cell recordings, k decreased by 1-3 mV in 30 min.
IKv-A and IKv-B May Represent Two States of the Same Channel
Purinergic stimulation may convert IKv-A into IKv-B in whole-cell experiments. The total amount of IKv did not change significantly with purinergic stimulation, but the relative contributions of IKv-A and IKv-B to the total IKv did change. After ATP total IKv decreased 4 ± 4% in 11 whole-cell experiments and increased 20 ± 10% in 12 perforated-patch experiments. The decrease in IKv in the whole-cell recordings is similar to current run down without ATP exposure. Fig. 8 A shows steady state inactivation voltage relations before and after ATP in a whole-cell recording. Maximum IKv-A was reduced by 0.5 nA after ATP, and maximum IKv-B increased by 0.5 nA, leaving total IKv unchanged. In whole-cell recordings in which the two current components were clearly identifiable after ATP, such as that in Fig. 8 A, there was a correlation between the decrease in IKv-A and increase in IKv-B induced by ATP as shown in Fig. 8 B. The correlation was strongest in cells exposed to ATP in the whole-cell configuration. In perforated-patch experiments, total IKv increased after ATP, and in many cells this was due to an increase in IKv-A amplitude without any change in IKv-B.
|
Purinergic Signaling Pathways Involved in IKv-A Modulation
The potency order for purinergic agonist effects on
IKv-A is consistent with activation of a P2 purinergic receptor, although our experiments cannot unequivocally distinguish the particular P2 receptor involved.
The minimum purine nucleotide concentration sufficient to decrease the peak amplitude of IKv-A in whole-cell experiments was used to assess agonist potency.
The agonist potency order found was: 2-MeSATP
(0.05-0.1 µM, n = 3) ATP (0.02-1 µM, n = 78) > ADP (10-100 µM, n = 5)
,
MeATP (100 µM, n = 3). Bath application of adenosine (100-1,000 µM, n = 3), UTP (40 µM, n = 4), or the P2X7 agonist BzATP
(2'-3'-O-[4-benzoylbenzoyl]-ATP) (Lee and Pappone,
unpublished observation) did not decrease the peak
amplitude of IKv-A. Thus, the agonist sensitivity is consistent with modulation by P2Y1 or any of several P2X
receptors, but not the P2X7 receptor (Rassendren et
al., 1997
). The concentration of ATP required to affect
IKv-A depended on the recording configuration. In
perforated-patch recordings, 5-10-fold higher ATP
concentrations (1-5 µM, n = 21) were required compared with whole-cell experiments, and ATP had to be
applied two to three times to cause similar decreases in
IKv-A amplitude.
The P2 receptor signaling of IKv modulation has unusual properties. P2Y1 receptors normally act through
G proteins, but the P2 receptor-mediated decrease in
IKv-A in whole-cell recordings was not altered by standard manipulations of G protein function. Internal exposure to 1 mM GTPS (guanosine 5'-O-[3-thiotriphosphate]; n = 6), AlF4, GDP
S (guanosine 5'-O-[2-thiodiphosphate]), pretreatment with pertussis toxin, or
ATP-free solutions did not affect IKv-A or its response
to externally applied ATP (Lee and Pappone, manuscript submitted for publication). P2X receptors usually act as ion channels and can trigger intracellular signals by carrying Ca2+ influx. However, in whole-cell experiments where extracellular Ca2+ was removed and
intracellular Ca2+ was buffered with EGTA to <20 nM
(n = 6), ATP stimulated IKv-A decreases similar to
those seen when external Ca2+ was present and internal Ca2+ was unbuffered (n = 10). Thus, the signaling
pathway does not fit nicely into either the G protein-
linked P2Y or the channel-forming P2X family of P2 receptor.
Activation of membrane receptors often initiates phosphorylation, phospholipid degradation, or alters cytoskeletal function, but manipulations to these pathways failed to mimic or affect the ATP-stimulated decrease in IKv-A in whole-cell recordings. 10-fold lower ATP concentrations were effective in decreasing IKv-A in whole-cell as compared with perforated-patch experiments, whether or not the internal solution contained ATP. Activation of protein kinase A with 1 mM 8-bromo-cAMP (n = 3) or 5 µM forskolin (n = 4) in perforated-patch recordings, or protein kinase C with 1.6 nM PMA (n = 13) in whole-cell experiments did not decrease IKv-A amplitude. Induction of nitric oxide production with Na-nitroprusside or a pipette solution containing cGMP (Lee and Pappone, unpublished observations) were also ineffective. In whole-cell recordings, the phospholipase products phosphatidic acid (Lee and Pappone, unpublished observation) or 1-100 µM arachidonic acid (n = 6) failed to mimic the ATP-induced decrease in IKv amplitude. Altering cytoskeletal function by pretreatment with cytochalasin or phalloidin (Lee and Pappone, unpublished observations) also did not affect the ATP-mediated decrease in IKv in whole-cell recordings. While negative results are not conclusive, the inadequacy of these many agents in affecting IKv modulation by ATP suggests that the signaling may occur through an unusual pathway.
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Our results demonstrate that P2 receptor stimulation modulates both voltage-gated K+ current components, IKv-A and IKv-B, present in rat brown adipocytes, as summarized in Table IV. Extracellular ATP causes negative shifts in the voltage dependence of inactivation and activation of IKv-A, the component activated by membrane depolarizations in the physiological range. ATP also seems to convert IKv-A into IKv-B, the component that is inactive under normal conditions. These effects of ATP on voltage-gated K+ current gating are large, consistent, irreversible, and activated by nanomolar concentrations of ATP in whole-cell recordings. In perforated-patch recordings, ATP causes qualitatively similar changes in IKv-A and IKv-B, but the effects are smaller, more variable, and require micromolar ATP. The characteristics of the ATP response in perforated-patch recordings are such that in vivo ATP could promote or reduce activation of IKv by membrane depolarization, depending on the strength and frequency of the stimulation.
|
Possible Mechanism of IKv Modulation
ATP causes both a hyperpolarizing shift in IKv-A voltage dependence, without a change in steepness, as well as an apparent conversion of IKv-A into IKv-B. ATP causes both the conductance-voltage relation and voltage dependence of inactivation for IKv-A to move continuously along the voltage axis, with the extent of the negative shift dependent on the stimulus strength. ATP also causes the amounts of IKv-A and IKv-B to change without producing discernible intermediate components. If a single process were responsible for the hyperpolarizing shift in IKv-A inactivation and IKv interconversion, then the hyperpolarizing shift in inactivation would be the result of a conversion of IKv-A to IKv-B. The expectation would be that the voltage dependence of IKv-A would not change as the current interconverted. Instead, the data show that the hyperpolarizing shifts in the voltage dependence of IKv-A can be graded and accompanied with significant current interconversion (Figs. 4 and 8), indicating that ATP modulates the hyperpolarizing shift in IKv-A and the interconversion through different processes.
The continuous hyperpolarizing shift in the voltage
dependence of IKv-A inactivation without any change
in slope cannot be explained by a mechanism where
ATP modulates only a few sites. A simple model, with
four modulatory sites, each causing a 20-mV shift in
inactivation voltage dependence, predicts that Kv current components with intermediate voltage dependence would be seen, and that the slope of voltage dependence would flatten. Neither occurred, indicating
that the process controlling the IKv-A inactivation shift
by ATP involves more than a few modulatory sites and/
or is quite complex. It is also unlikely that the hyperpolarizing shift in voltage dependence can be explained
by ATP-dependent phosphorylation or dephosphorylation of the channel protein, since the hyperpolarizing
shifts in IKv gating are similar with or without ATP in
the pipette. Possibly the ATP-induced hyperpolarizing
shift in IKv-A voltage dependence arises from changes
in channel interactions with the cytoskeleton (Johnson
et al., 1997
), changes in the membrane lipid composition (Ji et al., 1993
), or altered association of the channel with regulatory subunits (Jan and Jan, 1997
). Cytoskeletal elements can modulate Ca2+ currents through
phosphorylation-dependent pathways (Johnson et al.,
1997
) and fatty acids can bind to and affect the function of the cytoskeleton (Packham et al., 1991
; Exton,
1997
). ATP dramatically increases brown adipocyte
membrane trafficking, resulting in up to a doubling of
membrane capacitance (Pappone and Lee, 1996
). The
incorporation of new membrane may cause changes in
the plasma membrane lipid composition, involve remodeling of the cytoskeleton, or insert subunits that
modify IKv gating behavior. Increases in membrane
trafficking could also change the number and type of
IKv channels present in the membrane. ATP does not
alter total IKv in whole-cell preparations but does in
perforated-patch recordings. The increase in total IKv
could be explained by an increase in the number of Kv
channels, since exocytosis is more robust in perforated-patch than whole-cell recordings (Lee and Pappone, manuscript submitted for publication). P2 receptor
stimulation can also activate phospholipases in other
cell types (Boyer et al., 1989
; el-Moatassim and Dubyak,
1992
; Wang et al., 1992
; Humphreys and Dubyak,
1996
) and the generated fatty acids can cause hyperpolarizing shifts in the voltage dependence of voltage-sensitive K+ current gating (Honore et al., 1994
).
In contrast to the shift in voltage dependence, the apparent conversion of IKv-A into IKv-B by ATP could be
explained by a mechanism involving only a single site.
Since the conversion is more prominent in whole-cell
than in perforated-patch experiments, the conversion
from IKv-A to IKv-B may depend on immobile factors while the conversion of IKv-B to IKv-A may depend on
soluble components. One possibility is that purinergic
stimulation may lead to a change in the gating mode of
IKv-A by modifying interactions with regulatory subunits, as seen in Na+ channels (Ji et al., 1994
) and Maxi
K+ channels (reviewed in Jan and Jan, 1997
).
Potential Signaling Pathways
The potency order of different purinergic receptor agonists in decreasing IKv-A is consistent with stimulation
of any of several P2 receptor types (Barnard et al., 1997;
Burnstock, 1997
). Brown adipocytes have several different P2 receptors (Lee and Pappone, manuscript submitted for publication) that cause increases in cytosolic
Ca2+, membrane turnover, and conductance (Pappone
and Lee, 1996
; Lee and Pappone, 1997a
). The increases in brown adipocyte cytosolic Ca2+ by ATP are
consistent with G protein activation of phospholipase C, while the increases in membrane trafficking are resistant to G protein manipulations (Pappone and Lee,
1996
; Lee and Pappone, 1997a
; Lee and Pappone,
manuscript submitted for publication). The purinergic
receptor(s) active in modulating IKv show similar insensitivity to activation or inhibition of G protein function and to the absence of cytosolic ATP. The agonist
sensitivity of IKv modulation is consistent with mediation by a P2Y1 receptor or any of several of the P2X receptors (Barnard et al., 1997
; Burnstock, 1997
). Although P2Y receptor actions usually involve G proteins,
a G protein-independent pathway has been reported for heterologously expressed P2Y1 receptors (O'Grady
et al., 1996
). Signaling via a P2X receptor seems less
likely. P2X receptors usually form ligand gated cation
channels (Bean, 1992
; Surprenant et al., 1995
), but the
changes in IKv function by ATP were not accompanied
by increases in membrane conductance in whole-cell experiments or in perforated-patch recordings with
Ca2+-sensitive conductances blocked. Nonionotropic
mechanisms have been described for the P2X7 receptor
(el-Moatassim and Dubyak, 1992
; Humphreys and Dubyak, 1996
; Zou et al., 1997
). However, the potent P2X7
receptor agonist BzATP (Rassendren et al., 1997
) is ineffective in modulating IKv in brown adipocytes (Lee
and Pappone, unpublished observation). Thus, we cannot yet draw any conclusions as to which P2 receptor
regulates IKv.
Our whole-cell results show that neither the ATP-induced shift in IKv-A voltage dependence nor the conversion of IKv-A into IKv-B require soluble factors, suggesting the signaling components for these effects are
immobile. However, in perforated-patch recordings, the shifts in IKv voltage dependence are attenuated,
suggesting that mobile components are involved in signaling the recovery reactions. A similar lack of Ca2+ or
cytosolic ATP dependence of P2 receptor modulation
of ionic currents has been observed previously (Qu et
al., 1993a; Thomas and Hume, 1993
; Matsuura and
Ehara, 1996
; Matsuura et al., 1996a
). P2 receptor activation of muscarinic K+ currents in heart (Matsuura et
al., 1996a
) and K+ currents in skeletal muscle (Thomas
and Hume, 1993
) involve membrane delimited pathways. It will be interesting to determine whether new
signaling pathways underlie the modulation of brown
fat IKv by P2 receptor activation.
Possible Functions of IKv Modulation
Voltage-gated K currents are important for regulating
cell proliferation, volume regulation, and Ca2+ signaling in a variety of nonexcitable cells (Nilius and Wohlrab, 1992; Deutsch and Chen, 1993
; Lin et al., 1993
). In
brown adipocytes, IKv is necessary for proliferation of
cultured cells (Pappone and Ortiz-Miranda, 1993
), but
not for norepinephrine-induced thermogenesis (Pappone and Lucero, 1992
), suggesting that IKv may have
a specific functional role in brown adipocyte growth
and development. Proliferation of brown adipocytes is
promoted by P2 receptor stimulation (Barsoum et al.,
1998
; Wilson, Barsoum, Wilson, and Pappone, manuscript submitted for publication), suggesting that modulation of IKv by ATP may be linked to the proliferative
responses. As occurs in other cell types, IKv in brown
adipocytes could be linked to mitogenesis or differentiation through volume regulatory pathways (Deutsch,
1990
), or Ca2+ signaling (Lin et al., 1993
; Verheugen et
al., 1997
). Thus, ATP modulation of IKv gating may
regulate either cell volume responses or agonist-activated extracellular Ca2+ entry in brown adipocytes, and
these changes in cell volume or cytosolic Ca2+ could be
involved in the ATP effects on cell proliferation.
Potential Sources of ATP
There are several potential sources of purine nucleotides in brown fat, all of which may be activated with
sympathetic stimulation. During periods of high sympathetic nerve activity, as occurs with cold exposure or
overfeeding, ATP may be released with norepinephrine (Lagercrantz, 1976; Ellis and Burnstock, 1989
; Westfall
et al., 1990
). Mast cells are abundant in brown fat tissue
and possibly also release ATP (Rothwell et al., 1984
; Osipchuk and Cahalan, 1992
; Desautels et al., 1994
).
Lastly, sympathetic activation of metabolism or subsequent hypoxia may cause brown fat cells themselves to
release ATP, as has been described for hepatocytes and
epithelial cells (Abraham et al., 1993
; Reisin et al.,
1994
; Prat et al., 1996
; Wang et al., 1996
). Extracellular
ATP levels in brown fat are not known, but our results
suggest that nanomolar concentrations of ATP could
evoke significant responses.
Relation to White Fat
Recent findings indicate that brown adipocytes and
white adipocytes have very similar functions, gene expression, and cell signaling systems. Both cell types can
store, release, or waste metabolic energy. The main difference between the tissues is whether energy storage
or wasting predominates (reviewed in Himms-Hagen, 1992; Lonnroth and Smith, 1992
). The conductance
properties and P2 receptor responses of white adipocytes have not been as well characterized as those of
brown fat cells. However, to the extent that they are
known, white fat resembles brown fat. Similar IKv is
present in white fat, and ATP causes similar changes in
IKv and activates membrane exocytosis as in brown adipocytes (Lee and Pappone, 1997b
). Thus, purinergic
stimulation may also regulate the function of white adipocytes.
Summary
We find that P2 receptor activation modulates the amount and voltage dependence of activatable voltage-gated K+ currents in brown adipocytes. Extracellular ATP is likely to be increased with sympathetic stimulation of brown fat and could either augment or reduce the available IKv, depending on the stimulus strength and duration. Since IKv is known to be essential for brown adipocyte proliferation, modulation of IKv by extracellular ATP could be an important component of sympathetic regulation of adipocyte number. P2 receptors and K+ channels could prove to be effective sites for pharmacological manipulation of adipocyte growth and development.
![]() |
FOOTNOTES |
---|
Address correspondence to Pamela A. Pappone, Section of Neurobiology, Physiology and Behavior, One Shields Avenue, University of California, Davis, CA 95616. Fax: 530-752-5582; E-mail: papappone{at}ucdavis.edu
Original version received 7 July 1998 and accepted version received 14 October 1998.
Dr. Wilson's current address is Department of Physiology & Cell Biology/351, University of Nevada School of Medicine, Reno, NV 89557.The authors thank Dr. Sherwin Lee for helpful discussions and manuscript review, Drs. Martin Wilson and Martha O'Donnell for critical review of the manuscript, Ken Kunisaki, Jeff Pham, Joel Isaac Barthelow, and Christina Stroup for culturing cells, and Jock Hamilton for technical assistance.
This work was supported by National Institutes of Health grant GM-44840.
![]() |
Abbreviations used in this paper |
---|
HP, holding potential; IKv, voltage-dependent K+ current.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
1. | Abraham, E.H., A.G. Prat, L. Gerweck, T. Seneveratne, R.J. Arceci, R. Kramer, G. Guidotti, and H.F. Cantiello. 1993. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA 90: 312-316 [Abstract]. |
2. |
Armstrong, C.M., and
F. Bezanilla.
1974.
Charge movement associated with the opening and closing of the activation gates of the
Na channels.
J. Gen. Physiol
63:
533-552
|
3. | Barnard, E.A., J. Simon, and T.E. Webb. 1997. Nucleotide receptors in the nervous system: an abundant component using diverse transduction mechanisms. Mol. Neurobiol 15: 103-129 [Medline]. |
4. | Barsoum, M., S. Wilson, B. Wilson, and P. Pappone. 1998. Purine nucleotides modulate pre-brown adipocyte proliferation. FASEB J 12: A636 . (Abstr.) . |
5. | Bean, B.P.. 1992. Pharmacology and electrophysiology of ATP-activated ion channels. Trends Pharmacol. Sci 13: 87-90 [Medline]. |
6. |
Boyer, J.L.,
C.P. Downes, and
T.K. Harden.
1989.
Kinetics of activation of phospholipase C by P2Y purinergic receptor agonists and
guanine nucleotides.
J. Biol. Chem
264:
884-890
|
7. |
Bronnikov, G.,
J. Houstek, and
J. Nedergaard.
1992.
Beta-adrenergic, cAMP-mediated stimulation of proliferation of brown fat
cells in primary culture. Mediation via beta 1 but not via beta 3 adrenoceptors.
J. Biol. Chem
267:
2006-2013
|
8. | Burnstock, G.. 1997. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology 36: 1127-1139 [Medline]. |
9. | Cahalan, M.D., and R.S. Lewis. 1988. Role of potassium and chloride channels in volume regulation by T lymphocytes. Soc. Gen. Physiol. Ser 43: 281-301 [Medline]. |
10. | Cole, K.S., and J.W. Moore. 1960. Potassium ion current in the squid giant axon: dynamic characteristic. Biophys. J 1: 1-14 [Medline]. |
11. |
Dasso, L.,
E. Connolley, and
J. Nedergaard.
1990.
![]() ![]() |
12. | Dave, S., and D.J. Mogul. 1996. ATP receptor activation potentiates a voltage-dependent Ca channel in hippocampal neurons. Brain Res 715: 208-216 [Medline]. |
13. |
Desautels, M.,
A. Wollin,
I. Halvorson,
D.V. Muralidhara, and
J. Thornhill.
1994.
Role of mast cell histamine in brown adipose tissue thermogenic response to VMH stimulation.
Am. J. Physiol
266:
R831-R837
|
14. | Deutsch, C.. 1990. K+ channels and mitogenesis. Prog. Clin. Biol. Res. 334: 251-271 [Medline]. |
15. | Deutsch, C., and L.Q. Chen. 1993. Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation. Proc. Natl. Acad. Sci. USA. 90: 10036-10040 [Abstract]. |
16. |
el-Moatassim, C., and
G.R. Dubyak.
1992.
A novel pathway for the
activation of phospholipase D by P2z purinergic receptors in
BAC1.2F5 macrophages.
J. Biol. Chem
267:
23664-23673
|
17. | Ellis, J.L., and G. Burnstock. 1989. Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens. Br. J. Pharmacol 97: 1157-1164 [Abstract]. |
18. |
Exton, J.H..
1997.
Phospholipase D: enzymology, mechanisms of
regulation, and function.
Physiol. Rev
77:
303-320
|
19. |
Felipe, A.,
D.J. Snyders,
K.K. Deal, and
M.M. Tamkun.
1993.
Influence of cloned voltage-gated K+ channel expression on alanine
transport, Rb+ uptake, and cell volume.
Am. J. Physiol
265:
C1230-C1238
|
20. |
Geloen, A.,
A.J. Collet,
G. Guay, and
L.J. Bukowiecki.
1988.
Beta-adrenergic stimulation of brown adipocyte proliferation.
Am. J. Physiol
254:
C175-C182
|
21. | Girardier, L., and G. Schneider-Picard. 1983. Alpha and beta-adrenergic mediation of membrane potential changes and metabolism in rat brown adipose tissue. J. Physiol. (Lond.) 335: 629-641 [Abstract]. |
22. | Graf, J., and D. Haussinger. 1996. Ion transport in hepatocytes: mechanisms and correlations to cell volume, hormone actions and metabolism. J. Hepatol 24: 53-77 [Medline]. |
23. | Hamill, O.P., A. Marty, E. Neher, B. Sakmann, and F.J. Sigworth. 1981. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch. 391: 85-100 [Medline]. |
24. | Himms-Hagen, J.. 1989. Brown adipose tissue thermogenesis and obesity. Prog. Lipid Res 28: 67-115 [Medline]. |
25. | Himms-Hagen, J. 1992. Brown adipose tissue metabolism. In Obesity. P. Björntorp and B.N. Brodoff, editors. J.B. Lippincott Co., Philadelphia. 15-34. |
26. | Honore, E., J. Barhanin, B. Attali, F. Lesage, and M. Lazdunski. 1994. External blockade of the major cardiac delayed-rectifier K+ channel (Kv1.5) by polyunsaturated fatty acids. Proc. Natl. Acad. Sci. USA. 91: 1937-1941 [Abstract]. |
27. | Horn, R., and A. Marty. 1988. Muscarinic activation of ionic currents measured by a new whole-cell recording method. J. Gen. Physiol 92: 145-159 [Abstract]. |
28. | Horowitz, J.M., J. Hamilton, and B.A. Horwitz. 1983. Catecholamine-induced changes in transmembrane potential and temperature in normal and dystrophic hamster brown adipose tissue. Life Sci 32: 725-731 [Medline]. |
29. | Horwitz, B., J.S. Hamilton, M.T. Lucero, and P.A. Pappone. 1989. Catecholamine-induced changes in activated brown adipocytes. In Colloque Inserm (National Institute of Health and Medical Research) Colloquium, Vol. 193. Living in the Cold); Second International Symposium, Le Hohwald, France, April 23-29, 1989. A. Malan and B. Canguilhem, editors. John Libbey Eurotext. Paris. 377-386. |
30. | Humphreys, B.D., and G.R. Dubyak. 1996. Induction of the P2z/ P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J. Immunol 157: 5627-5637 [Abstract]. |
31. |
Jan, L.Y., and
Y.N. Jan.
1997.
Ways and means for left shifts in the
MaxiK channel.
Proc. Natl. Acad. Sci. USA
94:
13383-13385
|
32. | Ji, S., W. Sun, A.L. George Jr., R. Horn, and R.L. Barchi. 1994. Voltage-dependent regulation of modal gating in the rat SkM1 sodium channel expressed in Xenopus oocytes. J. Gen. Physiol 104: 625-643 [Abstract]. |
33. | Ji, S., J.N. Weiss, and G.A. Langer. 1993. Modulation of voltage-dependent sodium and potassium currents by charged amphiphiles in cardiac ventricular myocytes. Effects via modification of surface potential. J. Gen. Physiol 101: 355-375 [Abstract]. |
34. |
Johnson, B.D.,
J.P. Brousal,
B.Z. Peterson,
P.A. Gallombardo,
G.H. Hockerman,
Y. Lai,
T. Scheuer, and
W.A. Catterall.
1997.
Modulation of the cloned skeletal muscle L-type Ca2+ channel by anchored cAMP-dependent protein kinase.
J. Neurosci.
17:
1243-1255
|
35. | Lagercrantz, H.. 1976. On the composition and function of large dense cored vesicles in sympathetic nerves. Neuroscience 1: 81-92 [Medline]. |
36. |
Lee, S.C.,
R. Nuccitelli, and
P.A. Pappone.
1993.
Adrenergically activated Ca2+ increases in brown fat cells: effects of Ca2+, K+, and
K channel block.
Am. J. Physiol.
264:
C217-C228
|
37. |
Lee, S.C., and
P.A. Pappone.
1997a.
Effects of P2 purinergic receptor stimulation in brown adipocytes.
Am. J. Physiol
273:
C679-C686
|
38. | Lee, S.C., and P.A. Pappone. 1997b. Membrane responses to extracellular ATP in rat isolated white adipocytes. Pflügers Arch. 434: 422-428 [Medline]. |
39. | Lin, C.S., R.C. Boltz, J.T. Blake, M. Nguyen, A. Talento, P.A. Fischer, M.S. Springer, N.H. Sigal, R.S. Slaughter, M.L. Garcia, et al . 1993. Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J. Exp. Med 177: 637-645 [Abstract]. |
40. | Lonnroth, P., and U. Smith. 1992. Intermediary metabolism with an emphasis on lipid metabolism, adipose tissue, and fat cell metabolism: a review. In Obesity. P. Björntorp and B.N. Brodoff, editors. J.B. Lippincott Co., Philadelphia. 3-14. |
41. | Lucero, M.T., and P.A. Pappone. 1989. Voltage-gated potassium channels in brown fat cells. J. Gen. Physiol 93: 451-472 [Abstract]. |
42. | Lucero, M.T., and P.A. Pappone. 1990. Membrane responses to norepinephrine in cultured brown fat cells. J. Gen. Physiol 95: 523-544 [Abstract]. |
43. | Matsuura, H., and T. Ehara. 1996. Modulation of the muscarinic K+ channel by P2-purinoceptors in guinea-pig atrial myocytes. J. Physiol. (Lond.). 497: 379-393 [Abstract]. |
44. | Matsuura, H., and T. Ehara. 1997. Selective enhancement of the slow component of delayed rectifier K+ current in guinea-pig atrial cells by external ATP. J. Physiol. (Lond.). 503: 45-54 [Abstract]. |
45. | Matsuura, H., M. Sakaguchi, Y. Tsuruhara, and T. Ehara. 1996a. Activation of the muscarinic K+ channel by P2-purinoceptors via pertussis toxin-sensitive G proteins in guinea-pig atrial cells. J. Physiol. (Lond.) 490: 659-671 [Abstract]. |
46. | Matsuura, H., Y. Tsuruhara, M. Sakaguchi, and T. Ehara. 1996b. Enhancement of delayed rectifier K+ current by P2-purinoceptor stimulation in guinea-pig atrial cells. J. Physiol. (Lond.). 490: 647-658 [Abstract]. |
47. | Nakazawa, K., and K. Inoue. 1994. ATP reduces voltage-activated K+ current in cultured rat hippocampal neurons. Pflügers Arch. 429: 143-145 [Medline]. |
48. | Nedergaard, J., and O. Lindberg. 1982. The brown fat cell. Int. Rev. Cytol 74: 187-286 [Medline]. |
49. | Nilius, B., and W. Wohlrab. 1992. Potassium channels and regulation of proliferation of human melanoma cells. J. Physiol. (Lond.) 445: 537-548 [Abstract]. |
50. |
O'Grady, S.M.,
E. Elmquist,
T.M. Filtz,
R.A. Nicholas, and
T.K. Harden.
1996.
A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y1 receptor expression in Xenopus oocytes.
J. Biol. Chem
271:
29080-29087
|
51. | Osipchuk, Y., and M. Cahalan. 1992. Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature 359: 241-244 [Medline]. |
52. | Packham, M.A., M.A. Guccione, N.L. Bryant, and A. Livne. 1991. Incorporation of lipids labeled with various fatty acids into the cytoskeleton of aggregating platelets. Lipids 26: 485-491 [Medline]. |
53. |
Pappone, P.A., and
S.C. Lee.
1995.
![]() |
54. | Pappone, P.A., and S.C. Lee. 1996. Purinergic receptor stimulation increases membrane trafficking in brown adipocytes. J. Gen. Physiol 108: 393-404 [Abstract]. |
55. |
Pappone, P.A., and
M.T. Lucero.
1992.
Potassium channel block
does not affect metabolic responses of brown fat cells.
Am. J. Physiol
262:
C678-C681
|
56. |
Pappone, P.A., and
S.I. Ortiz-Miranda.
1993.
Blockers of voltage-gated K channels inhibit proliferation of cultured brown fat cells.
Am. J. Physiol
264:
C1014-C1019
|
57. |
Prat, A.G.,
I.L. Reisin,
D.A. Ausiello, and
H.F. Cantiello.
1996.
Cellular ATP release by the cystic fibrosis transmembrane conductance regulator.
Am. J. Physiol
270:
C538-C545
|
58. | Qu, Y., D.L. Campbell, and H.C. Strauss. 1993a. Modulation of L-type Ca2+ current by extracellular ATP in ferret isolated right ventricular myocytes. J. Physiol. (Lond.) 471: 295-317 [Abstract]. |
59. | Qu, Y., D.L. Campbell, A.R. Whorton, and H.C. Strauss. 1993b. Modulation of basal L-type Ca2+ current by adenosine in ferret isolated right ventricular myocytes. J. Physiol. (Lond.). 471: 269-293 [Abstract]. |
60. |
Rassendren, F.,
G.N. Buell,
C. Virginio,
G. Collo,
R.A. North, and
A. Surprenant.
1997.
The permeabilizing ATP receptor, P2X7.
Cloning and expression of a human cDNA.
J. Biol. Chem
272:
5482-5486
|
61. |
Reisin, I.L.,
A.G. Prat,
E.H. Abraham,
J.F. Amara,
R.J. Gregory,
D.A. Ausiello, and
H.F. Cantiello.
1994.
The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel.
J. Biol. Chem
269:
20584-20591
|
62. | Rothwell, N.J., M.J. Stock, and M.G. Wyllie. 1984. Effects of histamine antagonists on noradrenaline-stimulated blood flow and oxygen consumption of brown adipose tissue in the rat. Pflügers Arch. 402: 325-329 [Medline]. |
63. | Russ, U., T. Ringer, and D. Siemen. 1993. A voltage-dependent and a voltage-independent potassium channel in brown adipocytes of the rat. Biochim. Biophys. Acta 1153: 249-256 [Medline]. |
64. | Strange, K. 1994. Cellular and molecular physiology of cell volume regulation. CRC Press, Boca Raton, FL. 400 pp. |
65. | Surprenant, A., G. Buell, and R.A. North. 1995. P2X receptors bring new structure to ligand-gated ion channels. Trends Neurosci 18: 224-229 [Medline]. |
66. |
Thomas, S.A., and
R.I. Hume.
1993.
Single potassium channel currents activated by extracellular ATP in developing chick skeletal
muscle: a role for second messengers.
J. Neurophysiol
69:
1556-1566
|
67. | Verheugen, J.A., F. Le Deist, V. Devignot, and H. Korn. 1997. Enhancement of calcium signaling and proliferation responses in activated human T lymphocytes. Inhibitory effects of K+ channel block by charybdotoxin depend on the T cell activation state. Cell Calc 21: 1-17 [Medline]. |
68. |
Von zur Muhlen, F.,
B.D. Gonska, and
H. Kreuzer.
1997.
Inhibition
of the voltage-dependent calcium current by extracellular ATP in
hamster ventricular cardiomyocytes.
Am. J. Physiol
273:
H250-H256
|
69. | Wang, D.J., N.N. Huang, and L.A. Heppel. 1992. Extracellular ATP and ADP stimulate proliferation of porcine aortic smooth muscle cells. J. Cell Physiol 153: 221-233 [Medline]. |
70. |
Wang, Y.,
R. Roman,
S.D. Lidofsky, and
J.G. Fitz.
1996.
Autocrine
signaling through ATP release represents a novel mechanism for
cell volume regulation.
Proc. Natl. Acad. Sci. USA
93:
12020-12025
|
71. | Westfall, D.P., K.O. Sedaa, K. Shinozuka, R.A. Bjur, and I.L. Buxton. 1990. ATP as a cotransmitter. Ann. NY Acad. Sci 603: 300-310 [Medline]. |
72. | Wilson, S.M., and P.A. Pappone. 1996. Purinergic modulation of a voltage gated potassium channel in rat brown adipocytes. Biophys. J 70: A72 . (Abstr.) . |
73. | Yamashita, H., Y. Sato, T. Kizaki, S. Oh, J. Nagasawa, and H. Ohno. 1994. Basic fibroblast growth factor (bFGF) contributes to the enlargement of brown adipose tissue during cold acclimation. Pflügers Arch. 428: 352-356 [Medline]. |
74. | Zou, H., M. Ugur, J.V. Walsh, and J.J. Singer. 1997. Extracellular ATP increases the activity of a fatty acid- and stretch-activated K+ channel: possible role for fatty acids as second messengers. Biophys. J. 72: A264 . (Abstr.) . |